These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 38339343)
141. A new germline mutation in KIT associated with diffuse cutaneous mastocytosis in a Chinese family. Wang HJ; Lin ZM; Zhang J; Yin JH; Yang Y Clin Exp Dermatol; 2014 Mar; 39(2):146-9. PubMed ID: 24289326 [TBL] [Abstract][Full Text] [Related]
142. The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis. Erben P; Schwaab J; Metzgeroth G; Horny HP; Jawhar M; Sotlar K; Fabarius A; Teichmann M; Schneider S; Ernst T; Müller MC; Giehl M; Marx A; Hartmann K; Hochhaus A; Hofmann WK; Cross NC; Reiter A Ann Hematol; 2014 Jan; 93(1):81-8. PubMed ID: 24281161 [TBL] [Abstract][Full Text] [Related]
144. Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay. Kristensen T; Vestergaard H; Møller MB J Mol Diagn; 2011 Mar; 13(2):180-8. PubMed ID: 21354053 [TBL] [Abstract][Full Text] [Related]
145. Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies. Pardanani A; Lim KH; Lasho TL; Finke C; McClure RF; Li CY; Tefferi A Blood; 2009 Oct; 114(18):3769-72. PubMed ID: 19713463 [TBL] [Abstract][Full Text] [Related]
146. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Lim KH; Tefferi A; Lasho TL; Finke C; Patnaik M; Butterfield JH; McClure RF; Li CY; Pardanani A Blood; 2009 Jun; 113(23):5727-36. PubMed ID: 19363219 [TBL] [Abstract][Full Text] [Related]
147. Phenotypic and genotypic characteristics of mastocytosis according to the age of onset. Lanternier F; Cohen-Akenine A; Palmerini F; Feger F; Yang Y; Zermati Y; Barète S; Sans B; Baude C; Ghez D; Suarez F; Delarue R; Casassus P; Bodemer C; Catteau A; Soppelsa F; Hanssens K; Arock M; Sobol H; Fraitag S; Canioni D; Moussy A; Launay JM; Dubreuil P; Hermine O; Lortholary O; PLoS One; 2008 Apr; 3(4):e1906. PubMed ID: 18404201 [TBL] [Abstract][Full Text] [Related]
148. Recent advances in the understanding of mastocytosis: the role of KIT mutations. Orfao A; Garcia-Montero AC; Sanchez L; Escribano L; Br J Haematol; 2007 Jul; 138(1):12-30. PubMed ID: 17555444 [TBL] [Abstract][Full Text] [Related]
149. KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Garcia-Montero AC; Jara-Acevedo M; Teodosio C; Sanchez ML; Nunez R; Prados A; Aldanondo I; Sanchez L; Dominguez M; Botana LM; Sanchez-Jimenez F; Sotlar K; Almeida J; Escribano L; Orfao A Blood; 2006 Oct; 108(7):2366-72. PubMed ID: 16741248 [TBL] [Abstract][Full Text] [Related]
150. A novel K509I mutation of KIT identified in familial mastocytosis-in vitro and in vivo responsiveness to imatinib therapy. Zhang LY; Smith ML; Schultheis B; Fitzgibbon J; Lister TA; Melo JV; Cross NC; Cavenagh JD Leuk Res; 2006 Apr; 30(4):373-8. PubMed ID: 16183119 [TBL] [Abstract][Full Text] [Related]
151. Poor Applicability of Currently Available Prognostic Scoring Systems for Prediction of Outcome in Naumann N; Rudelius M; Lübke J; Christen D; Bresser J; Sotlar K; Metzgeroth G; Fabarius A; Hofmann WK; Panse J; Horny HP; Cross NCP; Reiter A; Schwaab J Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339343 [TBL] [Abstract][Full Text] [Related]